Adma Biologics reported $13.87M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Adma Biologics ADMA:US $ 13.87M 631.53K
Agile Therapeutics AGRX:US $ 12.76M 3.07M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Biocryst Pharmaceuticals BCRX:US $ 34.99M 8.67M
Dynavax Technologies DVAX:US $ 26.93M 5.85M
Kindred Biosciences KIN:US 5.87M 1.18M
Minerva Neurosciences NERV:US $ 3M 437.6K
Novavax NVAX:US $ 77.79M 4.63M
Omeros OMER:US $ 20.86M 699K
Takeda 4502:JP 212.01B 7.83B